Implantable loop recorders system Reveal ICM LINQ®, for Aortic Valve Stenosis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
IUCPQ, Quebec, CanadaAortic Valve Stenosis+5 MoreImplantable loop recorders system Reveal ICM LINQ®, - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will evaluate the incidence of high degree or complete AVB in patients with new-onset persistent left bundle branch block following TAVI, and will also assess the usefulness of the Reveal LINQ ICM for detecting significant arrhythmias in these patients.

Eligible Conditions
  • Aortic Valve Stenosis
  • Heart Block

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 5 Secondary · Reporting Duration: Within the first 3 years following TAVI procedure

1 Year
-Incidence of arrhythmic events identified by the IRL leading to a change in treatment or major adverse event
1Year
-Rate and time of onset of high degree or complete AVB
36-month follow-up
-Rate of high degree or complete AVB
6-month follow-up
Heart rate
Year 3
-Changes in left ventricular function and mitral regurgitation over time
-Electrocardiographic and device-related factors predicting the occurence of high degree or complete AVB in patients with new-onset LBBB after TAVI
-Rate of new atrial fibrillation or ventricular arrhythmias

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Implantable loop recorders Reveal ICM LINQ®,
1 of 1

Experimental Treatment

80 Total Participants · 1 Treatment Group

Primary Treatment: Implantable loop recorders system Reveal ICM LINQ®, · No Placebo Group · N/A

Implantable loop recorders Reveal ICM LINQ®,
Device
Experimental Group · 1 Intervention: Implantable loop recorders system Reveal ICM LINQ®, · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within the first 3 years following tavi procedure

Who is running the clinical trial?

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecLead Sponsor
35 Previous Clinical Trials
9,442 Total Patients Enrolled
5 Trials studying Aortic Valve Stenosis
765 Patients Enrolled for Aortic Valve Stenosis
Josep Rodes, MDPrincipal InvestigatorFondation IUCPQ
1 Previous Clinical Trials
222 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What is the aggregate participation rate in this investigation?

"Affirmative. The clinical trial registry, clinicialtrials.gov, indicates that recruitment for this study is ongoing and has been since it was initially posted on January 1st 2014. 80 patients are needed to be recruited from a single medical centre." - Anonymous Online Contributor

Unverified Answer

Is this clinical research actively recruiting participants?

"The clinical trial in question is actively seeking participants, having been uploaded to clinicaltrials.gov on January 1st 2014 and last edited September 20th 2021." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.